Literature DB >> 9779131

Decompressive craniectomy in patients with uncontrollable intracranial hypertension.

E Kunze1, J Meixensberger, M Janka, N Sörensen, K Roosen.   

Abstract

There has been controversial discussion about the benefits of decompressive craniectomy in patients with critically raised intracranial pressure (ICP) after severe head injury. The aim of this retrospective study was to analyze the results of secondary decompressive craniectomy in patients with uncontrollable raised ICP after maximum aggressive medical treatment. The data of 28 patients (mean age 22 years, range 8-44 years) with severe head injury and posttraumatic cerebral edema were analyzed retrospectively. Surgery was not indicated in patients with vast primary lesions, hypoxia, ischemic infarction, brainstem injuries and central herniation. The outcome was classified according to the Glascow Outcome Scale (GOS) after one year. The decompressive crainectomy was performed an average of 68 hours after trauma, and ICP (< 25 mm Hg) decreased always while cerebral perfusion pressure (CPP > 75 mm Hg) improved as well as cerebral blood flow and microcirculation to normal values. 15 patients (56%) had a good outcome after one year (GOS 4 + 5). 5 patients (18%) were severely disabled, 4 patients (14%) remained in vegetative state and 3 patients (11%) died. Decompressive craniectomy should be kept in mind as the last therapeutic step, especially in young patients with head injury and raised ICP, which is not controllable with conservative methods.

Entities:  

Mesh:

Year:  1998        PMID: 9779131     DOI: 10.1007/978-3-7091-6475-4_5

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  19 in total

1.  Analysis of complications following decompressive craniectomy for traumatic brain injury.

Authors:  Seung Pil Ban; Young-Je Son; Hee-Jin Yang; Yeong Seob Chung; Sang Hyung Lee; Dae Hee Han
Journal:  J Korean Neurosurg Soc       Date:  2010-09-30

2.  Severe traumatic brain injury in children--a single center experience regarding therapy and long-term outcome.

Authors:  Ulrich-Wilhelm Thomale; Daniela Graetz; Peter Vajkoczy; Asita S Sarrafzadeh
Journal:  Childs Nerv Syst       Date:  2010-02-23       Impact factor: 1.475

3.  Refractory intracranial hypertension and "second-tier" therapies in traumatic brain injury.

Authors:  Nino Stocchetti; Clelia Zanaboni; Angelo Colombo; Giuseppe Citerio; Luigi Beretta; Laura Ghisoni; Elisa Roncati Zanier; Katia Canavesi
Journal:  Intensive Care Med       Date:  2007-12-08       Impact factor: 17.440

Review 4.  Decompressive craniectomy for management of traumatic brain injury: an update.

Authors:  Leif-Erik Bohman; James M Schuster
Journal:  Curr Neurol Neurosci Rep       Date:  2013-11       Impact factor: 5.081

Review 5.  Does size matter? Decompressive surgery under review.

Authors:  Arthur R Kurzbuch
Journal:  Neurosurg Rev       Date:  2015-04-12       Impact factor: 3.042

6.  Efficacy and safety of durotomy after decompressive hemicraniectomy in traumatic brain injury.

Authors:  R B Moringlane; N Keric; F B Freimann; D Mielke; R Burger; D Duncker; V Rohde; K L V Eckardstein
Journal:  Neurosurg Rev       Date:  2017-02-09       Impact factor: 3.042

Review 7.  Decompressive Craniectomy.

Authors:  Clemens M Schirmer; Albert A Ackil; Adel M Malek
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

8.  Decompressive craniectomy following brain injury: factors important to patient outcome.

Authors:  Patrick O Eghwrudjakpor; Akaribari B Allison
Journal:  Libyan J Med       Date:  2010-01-07       Impact factor: 1.657

Review 9.  Imaging for the diagnosis and management of traumatic brain injury.

Authors:  Jane J Kim; Alisa D Gean
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

10.  Cerebral Edema in Traumatic Brain Injury: a Historical Framework for Current Therapy.

Authors:  Benjamin E Zusman; Patrick M Kochanek; Ruchira M Jha
Journal:  Curr Treat Options Neurol       Date:  2020-03-03       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.